Jove
Visualize
Contact Us

Related Experiment Videos

Pemphigus: current therapy.

Wayne S Rosenkrantz1

  • 1Animal Dermatology Clinic, Tustin, CA 92780, USA. AnDerm1@aol.com

Veterinary Dermatology
|March 20, 2004
PubMed
Summary
This summary is machine-generated.

Pemphigus is a challenging autoimmune skin disease with various forms like pemphigus vulgaris. This review details diagnostic approaches and therapeutic options, including common and alternative treatments for effective pemphigus management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pinnal Parakeratotic Hyperkeratosis Consistent With Zinc-Responsive Dermatosis in 16 French Bulldogs.

Veterinary dermatology·2025
Same author

Retrospective Evaluation of Clonality in Canine Erythema Multiforme.

Veterinary dermatology·2025
Same author

Efficacy of verdinexor for the treatment of naïve canine epitheliotropic cutaneous T-cell lymphoma: An open-label pilot study.

Veterinary dermatology·2024
Same author

In vitro efficacy of a topical antimicrobial mousse and shampoo at proximal and distal hair locations against Staphylococcus pseudintermedius and Staphylococcus schleiferi.

Veterinary dermatology·2023
Same author

The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis.

Veterinary dermatology·2023
Same author

Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity.

Veterinary dermatology·2023
Same journal

Fibroepithelial Polyps of the Ear Canal in Dogs: A Retrospective Analysis of 17 Cases.

Veterinary dermatology·2026
Same journal

Cutaneous Reactive Histiocytosis in Golden Retrievers: An Immunohistochemical Approach.

Veterinary dermatology·2026
Same journal

Cutaneous Equine Sarcoidosis: A Case Series and Investigation Into a Potential Association With Equine Gammaherpesviruses-2 and -5 in 30 Equids.

Veterinary dermatology·2026
Same journal

Osseous Changes in Young Cats With Inflammatory Aural Polyps: A Cone Beam Computed Tomography Analysis.

Veterinary dermatology·2026
Same journal

Fluorescent Light Energy (FLE) as an Adjunctive Therapy in Canine Cutaneous Epitheliotropic Lymphoma (CTCL).

Veterinary dermatology·2026
Same journal

Comparative Efficacy and Safety of Adjunctive 0.015% Triamcinolone Acetonide Topical Spray With Lokivetmab Versus Lokivetmab Monotherapy as 'Reactive Therapy' for Canine Atopic Dermatitis: A Randomised, Single-Blinded, Controlled Preliminary Trial.

Veterinary dermatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Dermatology
  • Autoimmune Diseases
  • Immunology

Background:

  • Pemphigus is a group of severe autoimmune blistering skin diseases.
  • These conditions are characterized by autoantibodies targeting desmosomal proteins, leading to intraepidermal blistering.
  • Pemphigus poses significant management and treatment challenges for clinicians.

Purpose of the Study:

  • To provide a comprehensive overview of the different clinical forms of pemphigus.
  • To discuss diagnostic strategies for pemphigus subtypes.
  • To review current and alternative therapeutic options for managing pemphigus.

Main Methods:

  • Literature review of pemphigus forms, diagnostics, and therapies.
  • Categorization of treatments into commonly used, current alternative, and additional alternative therapies.

Related Experiment Videos

  • Inclusion of specific drug classes and individual agents.
  • Main Results:

    • Identified key pemphigus subtypes: pemphigus foliaceus (PF), pemphigus erythematosus (PE), panepidermal pustular pemphigus (PPP), pemphigus vulgaris (PV), and paraneoplastic pemphigus (PNP).
    • Outlined diagnostic considerations for these subtypes.
    • Detailed a wide array of therapeutic agents, including glucocorticoids, immunosuppressants (azathioprine, chlorambucil, cyclosporin, tacrolimus, cyclophosphamide, mycophenolate mofetil), antibiotics (tetracycline), niacinamide, dapsone, sulfasalazine, chrysotherapy, and intravenous immunoglobulin (IVIG).

    Conclusions:

    • Effective management of pemphigus requires accurate diagnosis of its specific form.
    • A range of therapeutic strategies, from conventional to alternative, are available for pemphigus treatment.
    • Further research into optimal pemphigus therapy is warranted.